NASDAQ · OSRHW
OSR Holdings, Inc.
Healthcare · Biotechnology
$0.05
Down-$0.01 (-25.74%)
Updated Aug 16, 2026, 7:57 AM
SID Score
3.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.28M
- P/E ratio
- -0.84
- Dividend yield
- 0.00%
- 52-week range
- $0.03 – $0.10
- Volume
- 3.87K
- Avg. volume
- 44.73K
Price performance
OSRHW price history
1M range · 11 trading sessions · Daily adjusted prices
OSRHW closed at $0.05 after 11 trading sessions, up 15.57% for the selected period.
- Last close
- $0.05
- Period change
- +15.57%
- Period low
- $0.04
- Period high
- $0.05
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 14, 2026 | $0.0478 | $0.0478 | $0.0253 | $0.0475 | 3.87K |
| Aug 13, 2026 | $0.0479 | $0.0479 | $0.0286 | $0.0404 | 25.42K |
| Aug 12, 2026 | $0.0479 | $0.0485 | $0.0305 | $0.048 | 58.91K |
| Aug 11, 2026 | $0.0305 | $0.0479 | $0.0305 | $0.0479 | 518.77 |
| Aug 4, 2026 | $0.0479 | $0.0479 | $0.043 | $0.043 | 815.3 |
| Aug 3, 2026 | $0.043 | $0.0473 | $0.0429 | $0.0473 | 5.27K |
| Jul 31, 2026 | $0.048 | $0.048 | $0.0301 | $0.035 | 18.53K |
| Jul 28, 2026 | $0.0415 | $0.0415 | $0.0415 | $0.0415 | 199 |
| Jul 23, 2026 | $0.04 | $0.044 | $0.04 | $0.044 | 590 |
| Jul 22, 2026 | $0.0478 | $0.0479 | $0.035 | $0.0478 | 3.62K |
| Jul 21, 2026 | $0.0411 | $0.0411 | $0.0411 | $0.0411 | 401 |
Latest OSRHW news
The latest Smart Investors Daily articles mentioning OSRHW.
Stock researchCompany · Overview
OSRHW research
Overview
Company profile and research snapshot.
Company profile
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
